Cognitive symptoms are common in major depressive disorder and may help to identify patients who need treatment or who are not experiencing adequate treatment response. Digital tools providing ...real-time data assessing cognitive function could help support patient treatment and remediation of cognitive and mood symptoms.
The aim of this study was to examine feasibility and validity of a wearable high-frequency cognitive and mood assessment app over 6 weeks, corresponding to when antidepressant pharmacotherapy begins to show efficacy.
A total of 30 patients (aged 19-63 years; 19 women) with mild-to-moderate depression participated in the study. The new Cognition Kit app was delivered via the Apple Watch, providing a high-resolution touch screen display for task presentation and logging responses. Cognition was assessed by the n-back task up to 3 times daily and depressed mood by 3 short questions once daily. Adherence was defined as participants completing at least 1 assessment daily. Selected tests sensitive to depression from the Cambridge Neuropsychological Test Automated Battery and validated questionnaires of depression symptom severity were administered on 3 occasions (weeks 1, 3, and 6). Exploratory analyses examined the relationship between mood and cognitive measures acquired in low- and high-frequency assessment.
Adherence was excellent for mood and cognitive assessments (95% and 96%, respectively), did not deteriorate over time, and was not influenced by depression symptom severity or cognitive function at study onset. Analyses examining the relationship between high-frequency cognitive and mood assessment and validated measures showed good correspondence. Daily mood assessments correlated moderately with validated depression questionnaires (r=0.45-0.69 for total daily mood score), and daily cognitive assessments correlated moderately with validated cognitive tests sensitive to depression (r=0.37-0.50 for mean n-back).
This study supports the feasibility and validity of high-frequency assessment of cognition and mood using wearable devices over an extended period in patients with major depressive disorder.
DNAdigest's mission is to investigate and address the issues hindering efficient and ethical genomic data sharing in the human genomics research community. We conducted contextual interviews with ...human genomics researchers in clinical, academic or industrial R&D settings about their experience with accessing and sharing human genomic data. The qualitative interviews were followed by an online survey which provided quantitative support for our findings. Here we present the generalised workflow for accessing human genomic data through both public and restricted-access repositories and discuss reported points of frustration and their possible improvements. We discuss how data discoverability and accessibility are lacking in current mechanisms and how these are the prerequisites for adoption of best practices in the research community. We summarise current initiatives related to genomic data discovery and present a new data discovery platform available at http://nucleobase.co.uk.
Background
Parkinson disease (PD) is a neurodegenerative disease that has a wide range of motor symptoms, such as tremor. Tremors are involuntary movements that occur in rhythmic oscillations and are ...typically categorized into rest tremor or action tremor. Action tremor occurs during voluntary movements and is a debilitating symptom of PD. As noninvasive interventions are limited, there is an ever-increasing need for an effective intervention for individuals experiencing action tremors. The Microsoft Emma Watch, a wristband with 5 vibrating motors, is a noninvasive, nonpharmaceutical intervention for tremor attenuation.
Objective
This pilot study investigated the use of the Emma Watch device to attenuate action tremor in people with PD.
Methods
The sample included 9 people with PD who were assessed on handwriting and hand function tasks performed on a digitized tablet. Tasks included drawing horizontal or vertical lines, tracing a star, spiral, writing “elelelel” in cursive, and printing a standardized sentence. Each task was completed 3 times with the Emma Watch programmed at different vibration intensities, which were counterbalanced: high intensity, low intensity (sham), and no vibration. Digital analysis from the tablet captured kinematic, dynamic, and spatial attributes of drawing and writing samples to calculate mathematical indices that quantify upper limb motor function. APDM Opal sensors (APDM Wearable Technologies) placed on both wrists were used to calculate metrics of acceleration and jerk. A questionnaire was provided to each participant after using the Emma Watch to gain a better understanding of their perspectives of using the device. In addition, drawings were compared to determine whether there were any visual differences between intensities.
Results
In total, 9 people with PD were tested: 4 males and 5 females with a mean age of 67 (SD 9.4) years. There were no differences between conditions in the outcomes of interest measured with the tablet (duration, mean velocity, number of peaks, pause time, and number of pauses). Visual differences were observed within a small subset of participants, some of whom reported perceived improvement. The majority of participants (8/9) reported the Emma Watch was comfortable, and no problems with the device were reported.
Conclusions
There were visually depicted and subjectively reported improvements in handwriting for a small subset of individuals. This pilot study was limited by a small sample size, and this should be taken into consideration with the interpretation of the quantitative results. Combining vibratory devices, such as the Emma Watch, with task specific training, or personalizing the frequency to one’s individual tremor may be important steps to consider when evaluating the effect of vibratory devices on hand function or writing ability in future studies. While the Emma Watch may help attenuate action tremor, its efficacy in improving fine motor or handwriting skills as a stand-alone tool remains to be demonstrated.
IntroductionDaily physiotherapy is believed to mitigate the progression of cystic fibrosis (CF) lung disease. However, physiotherapy airway clearance techniques (ACTs) are burdensome and the evidence ...guiding practice remains weak. This paper describes the protocol for Project Fizzyo, which uses innovative technology and analysis methods to remotely capture longitudinal daily data from physiotherapy treatments to measure adherence and prospectively evaluate associations with clinical outcomes.Methods and analysisA cohort of 145 children and young people with CF aged 6–16 years were recruited. Each participant will record their usual physiotherapy sessions daily for 16 months, using remote monitoring sensors: (1) a bespoke ACT sensor, inserted into their usual ACT device and (2) a Fitbit Alta HR activity tracker. Real-time breath pressure during ACTs, and heart rate and daily step counts (Fitbit) are synced using specific software applications. An interrupted time-series design will facilitate evaluation of ACT interventions (feedback and ACT-driven gaming). Baseline, mid and endpoint assessments of spirometry, exercise capacity and quality of life and longitudinal clinical record data will also be collected.This large dataset will be analysed in R using big data analytics approaches. Distinct ACT and physical activity adherence profiles will be identified, using cluster analysis to define groups of individuals based on measured characteristics and any relationships to clinical profiles assessed. Changes in adherence to physiotherapy over time or in relation to ACT interventions will be quantified and evaluated in relation to clinical outcomes.Ethics and disseminationEthical approval for this study (IRAS: 228625) was granted by the London-Brighton and Sussex NREC (18/LO/1038). Findings will be disseminated via peer-reviewed publications, at conferences and via CF clinical networks. The statistical code will be published in the Fizzyo GitHub repository and the dataset stored in the Great Ormond Street Hospital Digital Research Environment.Trial registration numberISRCTN51624752; Pre-results.
Cognitive symptoms are an underrecognized aspect of depression that are often untreated. High-frequency cognitive assessment holds promise for improving disease and treatment monitoring. Although we ...have previously found it feasible to remotely assess cognition and mood in this capacity, further work is needed to ascertain the optimal methodology to implement and synthesize these techniques.
The objective of this study was to examine (1) longitudinal changes in mood, cognition, activity levels, and heart rate over 6 weeks; (2) diurnal and weekday-related changes; and (3) co-occurrence of fluctuations between mood, cognitive function, and activity.
A total of 30 adults with current mild-moderate depression stabilized on antidepressant monotherapy responded to testing delivered through an Apple Watch (Apple Inc) for 6 weeks. Outcome measures included cognitive function, assessed with 3 brief n-back tasks daily; self-reported depressed mood, assessed once daily; daily total step count; and average heart rate. Change over a 6-week duration, diurnal and day-of-week variations, and covariation between outcome measures were examined using nonlinear and multilevel models.
Participants showed initial improvement in the Cognition Kit N-Back performance, followed by a learning plateau. Performance reached 90% of individual learning levels on average 10 days after study onset. N-back performance was typically better earlier and later in the day, and step counts were lower at the beginning and end of each week. Higher step counts overall were associated with faster n-back learning, and an increased daily step count was associated with better mood on the same (P<.001) and following day (P=.02). Daily n-back performance covaried with self-reported mood after participants reached their learning plateau (P=.01).
The current results support the feasibility and sensitivity of high-frequency cognitive assessments for disease and treatment monitoring in patients with depression. Methods to model the individual plateau in task learning can be used as a sensitive approach to better characterize changes in behavior and improve the clinical relevance of cognitive data. Wearable technology allows assessment of activity levels, which may influence both cognition and mood.
Measuring chemical concentration is vital for understanding normal and disease physiology involving metabolism and signalling, but monitoring chemical concentrations in living systems poses a unique ...challenge because of biological heterogeneity. The purpose of this work is to develop a system able to monitor chemical concentrations in primary cultured cells, and apply it to the detection of oxygen, a nutritional status marker, and nitric oxide which is a signalling molecule. Both of these electroactive species are involved in angiogenesis which is the growth of new blood vessels, and a hallmark of cancer. The approach used in this study is to grow porcine endothelial cells onto bronectin-coated gold microelectrode arrays with diameter 25 μm and perform electrochemical measurement on them. An experimental protocol is developed for measurements of dissolved oxygen and nitric oxide around cells in their normal cell-culture environment. It includes developing instrumentation like a heating platform and silver reference microelectrode; data processing for automation and normalisation; and optimising voltammetry techniques. Culture medium is found to a ect electrochemical measurements by changing double layer capacitance, reaction rate constant and di usion. The measurement system is used to detect oxygen reduction around cells, and this is used to estimate their oxygen consumption rate. Nitric oxide produced by cells is also measured, and this is used to identify an angiogenic pathway leading to nitric oxide production by endothelial cells. Variability in cell measurements is shown to originate from the biological system rather than from sensor design. A novel electroanalytical technique for determining parameters of reversible redox systems is developed by experimentally testing an analytical solution for the current response to a large-amplitude sinusoidal voltage input. The technique is used to nd estimates for double layer capacitance, half wave potential and di usion coe cients for both potassium ferrocyanide and ruthenium hexaamine.
Measuring chemical concentration is vital for understanding normal and disease physiology involving metabolism and signalling, but monitoring chemical concentrations in living systems poses a unique ...challenge because of biological heterogeneity. The purpose of this work is to develop a system able to monitor chemical concentrations in primary cultured cells, and apply it to the detection of oxygen, a nutritional status marker, and nitric oxide which is a signalling molecule. Both of these electroactive species are involved in angiogenesis which is the growth of new blood vessels, and a hallmark of cancer. The approach used in this study is to grow porcine endothelial cells onto bronectin-coated gold microelectrode arrays with diameter 25 μm and perform electrochemical measurement on them. An experimental protocol is developed for measurements of dissolved oxygen and nitric oxide around cells in their normal cell-culture environment. It includes developing instrumentation like a heating platform and silver reference microelectrode; data processing for automation and normalisation; and optimising voltammetry techniques. Culture medium is found to a ect electrochemical measurements by changing double layer capacitance, reaction rate constant and di usion. The measurement system is used to detect oxygen reduction around cells, and this is used to estimate their oxygen consumption rate. Nitric oxide produced by cells is also measured, and this is used to identify an angiogenic pathway leading to nitric oxide production by endothelial cells. Variability in cell measurements is shown to originate from the biological system rather than from sensor design. A novel electroanalytical technique for determining parameters of reversible redox systems is developed by experimentally testing an analytical solution for the current response to a large-amplitude sinusoidal voltage input. The technique is used to nd estimates for double layer capacitance, half wave potential and di usion coe cients for both potassium ferrocyanide and ruthenium hexaamine.
PDF
